SABEEN LULU
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- CARMICHAEL, CA
- NPI
- 1104081298
- Received
- $118,373 in 127 records, 2019 to 2025
- As principal investigator
- $127,163 of research payments to others in 7 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 11 | $14,651 |
| 2024 | General payment | 15 | $15,169 |
| 2023 | General payment | 15 | $12,797 |
| 2022 | General payment | 28 | $23,097 |
| 2021 | General payment | 13 | $15,117 |
| 2020 | General payment | 14 | $14,654 |
| 2019 | General payment | 31 | $22,885 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Biogen, Inc. | 74 | $86,275 | 2019–2025 |
| GENZYME CORPORATION | 17 | $17,244 | 2019–2021 |
| Genentech USA, Inc. | 10 | $7,419 | 2020–2022 |
| EMD Serono, Inc. | 7 | $5,090 | 2019–2025 |
| TG Therapeutics, Inc. | 2 | $1,807 | 2024 |
| Horizon Therapeutics plc | 3 | $201 | 2022–2023 |
| Alexion Pharmaceuticals, Inc. | 3 | $102 | 2019–2022 |
| Celgene Corporation | 4 | $76 | 2019–2023 |
| ABBVIE INC. | 2 | $57 | 2025 |
| Genentech, Inc. | 2 | $44 | 2020–2022 |
| Novartis Pharmaceuticals Corporation | 2 | $37 | 2019–2023 |
| Lundbeck LLC | 1 | $16 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 36 | $93,538 |
| Consulting Fee | 21 | $20,365 |
| Food and Beverage | 65 | $3,225 |
| Travel and Lodging | 4 | $1,188 |
| Education | 1 | $55 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Biogen, Inc. | $4,110 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2025 | |
| 2025-11-12 | Biogen, Inc. | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2025 | |
| 2025-11-12 | Biogen, Inc. | $120 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-09-24 | Biogen, Inc. | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2025 | |
| 2025-09-09 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | Biogen, Inc. | $343 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, Neurology | 2025 | |
| 2025-08-08 | Biogen, Inc. | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2025 | |
| 2025-08-04 | Biogen, Inc. | $685 | Consulting Fee | Cash or cash equivalent | VUMERITY Drug, Neurology | 2025 | |
| 2025-04-29 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-07 | EMD Serono, Inc. | $3,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-02 | Biogen, Inc. | $171 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2024-12-03 | EMD Serono, Inc. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-19 | Biogen, Inc. | $1,614 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2024 | |
| 2024-10-17 | Biogen, Inc. | $1,614 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-09-25 | TG Therapeutics, Inc. | $1,688 | Consulting Fee | Cash or cash equivalent | BRIUMVI Drug, Immunology | 2024 | |
| 2024-09-20 | Biogen, Inc. | $125 | Food and Beverage | In-kind items and services | TECFIDERA Drug, Neurology | 2024 | |
| 2024-09-19 | TG Therapeutics, Inc. | $119 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2024-09-13 | Biogen, Inc. | $538 | Consulting Fee | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-09-10 | Biogen, Inc. | $1,614 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-06-19 | Biogen, Inc. | $3,228 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-04-10 | Biogen, Inc. | $269 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, Neurology | 2024 | |
| 2024-04-10 | Biogen, Inc. | $135 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-04-09 | Biogen, Inc. | $269 | Consulting Fee | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-03-05 | Biogen, Inc. | $3,228 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-03-05 | Biogen, Inc. | $116 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2024 | |
| 2024-02-07 | Biogen, Inc. | $12 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2024 | |
| 2023-12-14 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2023 | |
| 2023-11-16 | Biogen, Inc. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tysabri Biological, Neurology | 2023 | |
| 2023-11-15 | Biogen, Inc. | $98 | Food and Beverage | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2023-09-27 | Biogen, Inc. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tysabri Biological, Neurology | 2023 | |
| 2023-09-26 | Biogen, Inc. | $88 | Food and Beverage | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2023-07-19 | Biogen, Inc. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tysabri Biological, Neurology | 2023 | |
| 2023-07-19 | Biogen, Inc. | $90 | Food and Beverage | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2023-06-21 | Biogen, Inc. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-06-21 | Biogen, Inc. | $89 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-23 | Biogen, Inc. | $150 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, Neurology | 2023 | |
| 2023-05-11 | Biogen, Inc. | $11 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2023 | |
| 2023-04-04 | Biogen, Inc. | $125 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-03-08 | Horizon Therapeutics plc | $44 | Food and Beverage | In-kind items and services | UPLIZNA Drug, UPLIZNA | 2023 | |
| 2023-02-08 | Biogen, Inc. | $45 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-01-14 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2022-12-09 | Genentech USA, Inc. | $180 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-12-08 | Genentech USA, Inc. | $6,555 | Consulting Fee | Cash or cash equivalent | OCREVUS Biological, Immunology | 2022 | |
| 2022-12-08 | Genentech USA, Inc. | $368 | Travel and Lodging | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-12-08 | Genentech USA, Inc. | $243 | Travel and Lodging | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-12-02 | Genentech, Inc. | $27 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-11-30 | Horizon Therapeutics plc | $107 | Food and Beverage | In-kind items and services | UPLIZNA Drug, UPLIZNA | 2022 | |
| 2022-11-18 | Genentech USA, Inc. | $9 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-11-16 | Biogen, Inc. | $1,503 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2022 | |
| 2022-11-09 | Biogen, Inc. | $3,507 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-09 | Biogen, Inc. | $94 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-28 | EMD Serono, Inc. | $31 | Food and Beverage | Cash or cash equivalent | 2022 | ||
| 2022-10-27 | Alexion Pharmaceuticals, Inc. | $65 | Food and Beverage | In-kind items and services | SOLIRIS Biological, Rare Disease | 2022 | |
| 2022-10-26 | Horizon Therapeutics plc | $49 | Food and Beverage | In-kind items and services | UPLIZNA Drug, UPLIZNA | 2022 | |
| 2022-10-24 | Biogen, Inc. | $34 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-12 | Biogen, Inc. | $10 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2022 | |
| 2022-09-28 | Biogen, Inc. | $1,503 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2022 | |
| 2022-09-14 | Genentech USA, Inc. | $4 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-09-13 | Biogen, Inc. | $342 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-09-13 | Biogen, Inc. | $275 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-09-13 | Biogen, Inc. | $141 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-08-17 | Biogen, Inc. | $4,008 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2022 | |
| 2022-08-17 | Biogen, Inc. | $49 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2022 | |
| 2022-07-19 | Biogen, Inc. | $250 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-06-20 | Biogen, Inc. | $18 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2022 | |
| 2022-05-25 | EMD Serono, Inc. | $119 | Food and Beverage | Cash or cash equivalent | Mavenclad Drug, Neurology | 2022 | |
| 2022-03-23 | Biogen, Inc. | $3,507 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2022 | |
| 2022-03-23 | Biogen, Inc. | $88 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2022 | |
| 2022-03-17 | Genentech USA, Inc. | $3 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2021-12-15 | Biogen, Inc. | $3,255 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-12-15 | Biogen, Inc. | $62 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-12-15 | Biogen, Inc. | $15 | Travel and Lodging | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-12-08 | Biogen, Inc. | $3,255 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-12-08 | Biogen, Inc. | $97 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-08-26 | Biogen, Inc. | $1,395 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-08-11 | GENZYME CORPORATION | $1,911 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, Neurology | 2021 | |
| 2021-05-11 | GENZYME CORPORATION | $1,638 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, Neurology | 2021 | |
| 2021-04-22 | Biogen, Inc. | $853 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-04-13 | Genentech USA, Inc. | $17 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2021-03-24 | Biogen, Inc. | $1,395 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-02-26 | EMD Serono, Inc. | $1,200 | Consulting Fee | Cash or cash equivalent | Mavenclad Drug, Neurology | 2021 | |
| 2021-02-16 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2020-11-12 | Biogen, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2020 | |
| 2020-11-12 | Genentech USA, Inc. | $16 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2020 | |
| 2020-09-10 | Biogen, Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2020 | |
| 2020-08-17 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2020 | |
| 2020-03-10 | GENZYME CORPORATION | $2,984 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, Neurology | 2020 | |
| 2020-03-10 | GENZYME CORPORATION | $51 | Food and Beverage | In-kind items and services | AUBAGIO Drug, Neurology | 2020 | |
| 2020-02-18 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2020 | |
| 2020-02-18 | Biogen, Inc. | $36 | Food and Beverage | In-kind items and services | TECFIDERA Drug, NEUROLOGY | 2020 | |
| 2020-02-08 | GENZYME CORPORATION | $1,038 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, Neurology | 2020 | |
| 2020-02-07 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | AUBAGIO Drug, Neurology | 2020 | |
| 2020-02-03 | Genentech, Inc. | $17 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2020 | |
| 2020-01-27 | EMD Serono, Inc. | $24 | Food and Beverage | In-kind items and services | Mavenclad Drug, Neurology | 2020 | |
| 2020-01-23 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2020 | |
| 2020-01-23 | Biogen, Inc. | $102 | Food and Beverage | In-kind items and services | TECFIDERA Drug, NEUROLOGY | 2020 | |
| 2019-12-16 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | MS DISEASE STATE Drug | 2019 | |
| 2019-12-10 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-12-10 | Biogen, Inc. | $24 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-12-09 | Alexion Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | SOLIRIS Drug, Immunology | 2019 | |
| 2019-11-14 | Biogen, Inc. | $55 | Education | In-kind items and services | 2019 | ||
| 2019-11-11 | Celgene Corporation | $14 | Food and Beverage | In-kind items and services | Ozanimod Drug | 2019 | |
| 2019-10-29 | GENZYME CORPORATION | $2,266 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-10-29 | GENZYME CORPORATION | $51 | Food and Beverage | In-kind items and services | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-09-19 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-09-19 | Biogen, Inc. | $121 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-09-06 | GENZYME CORPORATION | $2,955 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-09-06 | GENZYME CORPORATION | $562 | Travel and Lodging | In-kind items and services | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-09-06 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-08-30 | Biogen, Inc. | $36 | Food and Beverage | In-kind items and services | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-08-26 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | PIPELINE-MS Drug | 2019 | |
| 2019-07-24 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-07-24 | Biogen, Inc. | $40 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-07-08 | Alexion Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | SOLIRIS Drug, Immunology | 2019 | |
| 2019-06-15 | Biogen, Inc. | $16 | Food and Beverage | In-kind items and services | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-05-03 | EMD Serono, Inc. | $115 | Food and Beverage | In-kind items and services | Mavenclad Biological, Neurology | 2019 | |
| 2019-04-29 | Celgene Corporation | $26 | Food and Beverage | In-kind items and services | Ozanimod Drug | 2019 | |
| 2019-04-11 | GENZYME CORPORATION | $2,266 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-04-11 | GENZYME CORPORATION | $55 | Food and Beverage | In-kind items and services | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-04-09 | Biogen, Inc. | $8 | Food and Beverage | In-kind items and services | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-03-28 | Biogen, Inc. | $19 | Food and Beverage | In-kind items and services | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-02-25 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-02-21 | Biogen, Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-02-21 | Biogen, Inc. | $121 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2019 | |
| 2019-01-28 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-01-26 | GENZYME CORPORATION | $1,379 | Consulting Fee | Cash or cash equivalent | AUBAGIO Drug, MULTIPLE SCLEROSIS | 2019 | |
| 2019-01-08 | Celgene Corporation | $18 | Food and Beverage | In-kind items and services | Ozanimod Drug | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2023-01-04 | Novartis Pharmaceuticals Corporation | DIGNITY HEALTH | $750 | Exploring the safety and tolerability of conversion to dose titrated Siponimod in patients with relapsing forms of multi | 2023 |
| 2022-07-07 | Novartis Pharmaceuticals Corporation | DIGNITY HEALTH | $4,500 | EXPLORING THE SAFETY AND TOLERABILITY OF CONVERSION TO DOSE TITRATED SIPONIMOD IN PATIENTS WITH RELAPSING FORMS OF MULTI | 2022 |
| 2022-03-17 | Roche Products Limited | DIGNITY HEALTH MEDICAL FOUNDATION | $12,000 | OBSERVATIONAL STUDY OF OCRELIZUMAB TREATED MULTIPLE SCLEROSIS PATIENTS US COMMITMENT | 2022 |
| 2020-07-21 | Novartis Pharmaceuticals Corporation | DIGNITY HEALTH | $8,000 | EXPLORING THE SAFETY AND TOLERABILITY OF CONVERSION TO DOSE TITRATED SIPONIMOD IN PATIENTS WITH RELAPSING FORMS OF MULTI | 2020 |
| 2019-12-16 | Genentech, Inc. | CATHOLIC HEALTHCARE WEST II | $5,436 | MNT CHORDS | 2019 |
| 2019-11-04 | Genentech, Inc. | CATHOLIC HEALTHCARE WEST II | $7,714 | MNT CHORDS | 2019 |
| 2019-02-12 | Novartis Pharmaceuticals Corporation | DIGNITY HEALTH | $88,762 | EXPLORING THE SAFETY AND TOLERABILITY OF CONVERSION TO DOSE TITRATED SIPONIMOD IN PATIENTS WITH RELAPSING FORMS OF MULTI | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Carmichael, CA, county Sacramento County, CA, state California; placed by its city name.
| Measure | Place (city or town) Carmichael, CA | County Sacramento County, CA | State California |
|---|---|---|---|
| Population B01003 | 76,948 | 1,594,006 | 39,287,377 |
| Population, 2020 census P1 | 79,793 | 1,585,055 | 39,538,223 |
| Median age B01002 | 40.1 | 37.5 | 37.9 |
| Under 18 B01001 | 20.5% | 22.9% | 22.0% |
| 65 and over B01001 | 20.7% | 15.3% | 15.7% |
| Households B11001 | 31,208 | 571,057 | 13,548,091 |
| Foreign born B05002 | 16.2% | 22.3% | 27.0% |
| Median household income B19013 | $85,914 | $92,175 | $99,122 |
| Median family income B19113 | $105,845 | $107,555 | $113,346 |
| Per capita income B19301 | $47,983 | $43,324 | $49,513 |
| Poverty rate B17001 | 12.6% | 12.5% | 12.0% |
| Unemployment rate B23025 | 7.3% | 6.7% | 6.6% |
| Civilian labor force B23025 | 38,510 | 805,946 | 20,068,466 |
| Mean commute (minutes) B08013 | 27.1 | 27.3 | 28.7 |
| Bachelor's degree or higher B15003 | 36.7% | 34.1% | 37.1% |
| Housing units B25001 | 33,048 | 598,385 | 14,644,735 |
| Owner-occupied B25003 | 52.2% | 59.0% | 55.9% |
| Renters B25003 | 47.8% | 41.0% | 44.1% |
| Median home value B25077 | $579,500 | $534,200 | $734,700 |
| Median gross rent B25064 | $1,702 | $1,790 | $2,036 |
| White, not Hispanic B03002 | 62.3% | 40.6% | 33.8% |
| Black B03002 | 6.2% | 9.0% | 5.2% |
| Hispanic or Latino B03002 | 15.5% | 24.2% | 40.2% |
| Asian B03002 | 7.8% | 17.6% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Carmichael, CA.
Comments